Columbia University Medical Center
NewYork-Presbyterian Hospital The University Hospital of Columbia and Cornell
September 14, 2008

An American Journal of Psychiatry study co-authored by Dr. Jeffrey Lieberman and published online today reports that the newer antipsychotics, when compared to older medications, were not more effective in treating schizophrenia in children and adolescents.

The study compared molindone, olanzapine and risperidone. According to a report in ScienceDaily, "Both olanzapine and risperidone were associated with significant weight gain and could put young patients at risk of developing heart disease and diabetes. In fact, the National Institute of Mental Health, which sponsored the study, halted recruitment into the olanzapine arm of the study because of the weight gain problem and the resulting increase in cholesterol and glucose levels."

Read more at ScienceDaily">For more details on this study, go to ScienceDaily

 

hora interior